For over 75 years, The Society of Memorial Sloan Kettering Cancer Center (MSK) has raised essential philanthropic funds to drive landmark innovations in cancer prevention, diagnosis, treatment and care at MSK. The Opening Night of TEFAF New York, held this past Thursday, benefited MSK programs supported by The Society and raised over $480,000.
TEFAF (The European Fine Art Foundation) represents the highest quality and connoisseurship; and has an unsurpassed reputation. The TEFAF New York exhibition brings 91 distinguished galleries together from around the world presenting modern and contemporary art, jewelry, antiquities, and design.
The Opening Night of TEFAF included an exclusive preview of the show, with drinks and appetizers, before it opened to the public for its full run from May 10th through 14th.
Prada was the returning sponsor of this year’s event.
Guests included Tory Burch, Alessia Fendi, Martha Glass, Jamee and Peter Gregory, Charlotte Groeneveld, Phyllis Hattis, Yaz and Valentín Hernandez, Robyn Joseph, Brooke and Oliver Kennan, Lauren and Sean Kelly, Meghan Klopp, Jeremy Kost, Delphine and Reed Krakoff, Elizabeth Loomis, Eva Lorenzotti, Claudia Overstrom, Polina Proshkina, Renee Rockefeller, Mark Ronson and Grace Gummer, Brooke Sinclair, Martha Stewart, Jamie Tisch, and Vera Wang.
PRESIDENT, THE SOCIETY OF MSK
Austen Cruz
CHAIR, ASSOCIATES COMMITTEE
Jill Bikoff, Leslie Coleman, Judy Gordon Cox, Jennifer Creel, Nathalie Pierrepont Danilovich, Andrea Glimcher, Sallie Giordano, Anna Kennedy, Eleanora Kennedy, Sevda Kleinman, Melanie McLennan, Holly Peterson, Amanda Taylor
EVENT CO-CHAIRS
The Society of Memorial Sloan Kettering Cancer Center – founded in 1946 to raise funds for patient care – is a volunteer organization dedicated to promoting the well-being of patients, supporting cancer research, and providing public education on the prevention, early detection, and treatment of cancer.
Society volunteers work in close collaboration with the physicians and staff of MSK to support the Center’s mission of delivering the best cancer care to its patients while at the same time, providing comfort and caring to our patients and their families who come to the Center for treatment from all over the world.
Memorial Sloan Kettering Cancer Center (MSK) is a world leader in patient care, research, and education. With expertise in over 400 cancer types and almost 2,000 clinical trials underway at a given time, MSK makes a massive difference in the lives of millions of people facing cancer around the world.
